2020
DOI: 10.1016/j.bmc.2019.115263
|View full text |Cite
|
Sign up to set email alerts
|

Anti-diabetic drugs recent approaches and advancements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
75
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(76 citation statements)
references
References 274 publications
0
75
0
1
Order By: Relevance
“…In addition, prolonged sulfonylurea's use is associated with progressive deterioration in β cell function, whereas the most common side effects of GLP-1 analogues are vomiting, nausea, diarrhea, and injection-site reactions [8]. The most common side effects of DPP-4 inhibitors are headache, nasopharyngitis, nausea, and excessive touchiness [9]. The side effects of α-glucosidase inhibiting drugs include diarrhea, abdominal pain, and flatulence [10] while urogenital tract infections, reduction in bone formation, orthostatic hypotension, euglycaemic ketoacidosis, and the volume depletion are adverse effects of SGLT2 inhibitors [2].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, prolonged sulfonylurea's use is associated with progressive deterioration in β cell function, whereas the most common side effects of GLP-1 analogues are vomiting, nausea, diarrhea, and injection-site reactions [8]. The most common side effects of DPP-4 inhibitors are headache, nasopharyngitis, nausea, and excessive touchiness [9]. The side effects of α-glucosidase inhibiting drugs include diarrhea, abdominal pain, and flatulence [10] while urogenital tract infections, reduction in bone formation, orthostatic hypotension, euglycaemic ketoacidosis, and the volume depletion are adverse effects of SGLT2 inhibitors [2].…”
Section: Introductionmentioning
confidence: 99%
“…Deficiency in insulin secretion, insulin action or both, results in chronic hyperglycemia, the main characteristic of diabetes mellitus [51], the main treatment to this condition being the use of anti-diabetic drugs that can control glucose levels in the blood [52].…”
Section: Antidiabeticmentioning
confidence: 99%
“…It is due, in 85-90% of total cases, to the poor or no response of receptors to insulin (type 2 diabetes mellitus), that increase blood glucose levels. Alternatively, type 1 diabetes mellitus, more frequent in children and teenagers, is imputable to the lack or deficiency of insulin, depending on the inability of pancreatic cells to produce it [168]. Diabetes is frequently associated to several complications, most notably cardiovascular and metabolic disorders.…”
Section: Antidiabetic Activitymentioning
confidence: 99%
“…One of the therapeutic approaches to treat diabetes consists of the inhibition of carbohydrate-hydrolyzing enzymes (such as α-amylase and α-glucosidase). The former is responsible for the breakdown of polysaccharides such as starch to monosaccharides [169], the latter breaks down carbohydrates into monosaccharide glucose, allowing its absorption by the intestine [168]. Acarbose, miglitol and voglibose, as well as other synthetic enzyme inhibitors, reduce the absorption rate of glucose, causing a reduction in postprandial glucose levels [170].…”
Section: Antidiabetic Activitymentioning
confidence: 99%